AtriCure, Inc. 10-Q filing
Filed 2026-05-06 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001323885-26-000023
- Form type
- 10-Q
- CIK
- 0001323885
- Primary document
- https://www.sec.gov/Archives/edgar/data/1323885/000132388526000023/atrc-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for AtriCure, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $141.2M | - | - |
| Cost Of Revenue | $31.9M | - | - |
| Gross Profit | $109.3M | - | - |
| Operating Income | $526,000 | - | - |
| Net Income | $108,000 | - | - |
| Eps Basic | 0 | - | - |
| Eps Diluted | 0 | - | - |
| Cash And Equivalents | $146.2M | - | - |
| Total Assets | $644.0M | - | - |
| Total Liabilities | $152.3M | - | - |
| Shareholders Equity | $491.7M | - | - |
| Operating Cash Flow | $-4.0M | - | - |
| Capital Expenditures | $3.9M | - | - |